Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis
Open Access
- 21 December 2009
- journal article
- research article
- Published by SAGE Publications in Dose-Response
- Vol. 8 (3), 285-300
- https://doi.org/10.2203/dose-response.09-036.chiang
Abstract
Our work in dogs has revealed a U-shaped dose response between selenium status and prostatic DNA damage that remarkably parallels the relationship between dietary selenium and prostate cancer risk in men, suggesting that more selenium is not necessarily better. Herein, we extend this canine work to show that the selenium dose that minimizes prostatic DNA damage also maximizes apoptosis—a cancer-suppressing death switch used by prostatic epithelial cells. These provocative findings suggest a new line of thinking about how selenium can reduce cancer risk. Mid-range selenium status (.67–.92 ppm in toenails) favors a process we call “homeostatic housecleaning”—an upregulated apoptosis that preferentially purges damaged prostatic cells. Also, the U-shaped relationship provides valuable insight into stratifying individuals as selenium-responsive or selenium-refractory, based upon the likelihood of reducing their cancer risk by additional selenium. By studying elderly dogs, the only non-human animal model of spontaneous prostate cancer, we have established a robust experimental approach bridging the gap between laboratory and human studies that can help to define the optimal doses of cancer preventives for large-scale human trials. Moreover, our observations bring much needed clarity to the null results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) and set a new research priority: testing whether men with low, suboptimal selenium levels less than 0.8 ppm in toenails can achieve cancer risk reduction through daily supplementation.Keywords
This publication has 72 references indexed in Scilit:
- Potential Stages for Prostate Cancer Prevention with Selenium: Implications for Cancer SurvivorsCancer Research, 2009
- Selenium as an Essential Micronutrient: Roles in Cell Cycle and ApoptosisMolecules, 2009
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other CancersJAMA, 2009
- Interaction between Single Nucleotide Polymorphisms in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate Cancer RiskCancer Research, 2008
- Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or seleniteCarcinogenesis: Integrative Cancer Research, 2008
- Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substratesMolecular Cancer Therapeutics, 2007
- Cancer Clues from Pet DogsScientific American, 2006
- Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triageProceedings of the National Academy of Sciences, 2006
- Serum selenium and risk of prostate cancer in U.S. blacks and whitesInternational Journal of Cancer, 2002
- A simple technique for quantitation of low levels of DNA damage in individual cellsExperimental Cell Research, 1988